COVID-19

NAFDAC Approves Pfizer-BioNTech COVID-19 Vaccine For Emergency Use

National Agency for Food and Drug Administration and Control (NAFDAC) has approved the use of the Pfizer-BioNTech COVID-19 vaccine for emergency use in Nigeria.

The agency’s Director-General, Mojisola Adeyeye announced this during a virtual meeting on Friday.

The development comes months after the Oxford-Astrazeneca COVID-19 vaccine was approved.

Nigeria started vaccinating people against coronavirus in March after it received 3.924m doses of AstraZeneca vaccine doses from COVAX facility.

Over one million doses of the vaccine have so far been administered across the country in the first phase of the vaccination programme, according to the National Primary Health Care Development Agency (NPHCDA).

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
%d bloggers like this: